Research Article
Salivary Distinctiveness and Modifications in Males with Diabetes and Behçet’s Disease
Table 5
Comparison of body mass index and biochemical and rheological parameters for inactive and active
Behçet disease patients (
).
| | Variable | Inactive patients () | Active patients () | |
| | Body mass index (BMI) (kg/m2) | 22.8 ± 3.13 | 25.4 ± 3.52 | 0.609 | | Elongation index at 60 Pa (EI60) (%) | 57.22 ± 4.34 | 59.34 ± 3.17 | 0.602 | | Plasma viscosity (PV) (cP) | 1.18 ± 0.05 | 1.29 ± 0.10 | 0.001 | | Blood viscosity native hematocrit, 230 s−1 (BVn230 s−1) (cP) | 4.02 ± 0.49 | 4.33 ± 0.47 | 0.401 | | 4.55 ± 0.49 | | Blood viscosity corrected hematocrit, 230 s−1 (BVc230 s−1) (cP) | 4.35 ± 0.29 | 5.04 ± 0.43 | 0.008 | | Red blood cell distribution width (RDW) | 12.06 ± 0.58 | 16.14 ± 1.46 | <0.001 | | Mean corpuscular volume (MCV) (femtoliters/cell (fL)) | 90.38 ± 4.74 | 88.27 ± 5.16 | 0.311 | | Mean corpuscular hemoglobin (MCH) (pictograms/cell (pg)) | 30.48 ± 1.42 | 29.53 ± 1.89 | 0.065 | | Mean corpuscular hemoglobin concentration (MCHC) (%) | 34.89 ± 0.91 | 34.22 ± 1.20 | 0.157 | | Hematocrit (Htc) (%) | 42.8 ± 3.58 | 39.2 ± 3.36 | 0.407 | | Leucocytes (Leu × 109/L) | 6.53 ± 1.08 | 7.80 ± 2.95 | 0.095 | | Erythrocyte aggregation at stasis (EA0) | 2.75 ± 0.94 | 4.15 ± 0.95 | 0.001 | | Erythrocyte aggregation at 3 s−1 (EA1) | 6.63 ± 0.94 | 7.92 ± 1.20 | 0.003 | | Fibrinogen (Fbg) (mg/dL) | 250 ± 51 | 315 ± 97 | 0.001 | | Total cholesterol (T-Chol) (mg/dL) | 211 ± 37 | 209 ± 39 | 0.611 | | Triglycerides (TG) (mg/dL) | 90 ± 40 | 108 ± 49 | 0.243 |
|
|
